According to a study published in a professional monothematic journal for practising doctors, Medical Council, personalization of therapy emerging as a strong foothold in modern medicine. This approach referring an individual strategy to each patient, consider individual symptoms of the patient and the particular clinical case.

This strategy should also be used to design rational analgesic therapy to treat patients with the most prevalent and socially significant ailments. Experts of different specialities like cardiologists, rheumatologists, clinical pharmacologists, and neurologists acknowledged the key perspectives of the prescription of NSAIDs, a widely used drug class of painkillers, comprising those employed to provide relief from musculoskeletal pain.

The practitioner should consider medical history data, diagnosis, the intensity of pain, the presence of comorbid diseases, risk factors for drug complications, and the planned duration of analgesic therapy while choosing NSAIDs. There are various types of NSAIDs; some are suitable for long-term pain management in chronic diseases like Etoricoxib and others for urgent acute pain therapy like Ketoprofen. The things to keep in consideration before treatment are patient safety, preventing NSAID associated complications and the duration of the particular drug administration authorized by the patient information leaflet. Further, as per recent findings, the launch of a new generic Etoricoxib extends the opportunities of analgesic therapy in Russia.